Cartalax - 10mg

1,800+ Verified Orders!

Cartalax - 10mg

€49,99
€79,99
38% OFF
38% OFF

Third Party Tested

14-Day Money Back Guarantee

Fast Delivery Worldwide

1,800+ Verified Orders!

Cartalax - 10mg

€49,99
€79,99
38% OFF
38% OFF

Third Party Tested

14-Day Money Back Guarantee

Fast Delivery Worldwide

Cartalax is a synthetic peptide composed of 10 amino acids, developed for its anti-inflammatory and regenerative effects, especially in the area of ​​cartilage, connective tissues and joint regeneration. Research focuses on its effects in osteoarthritis and ICH stability disorders.

Parameters
Value
Form
Lyophilized powder
Contents
10 mg
Concentration (test)
Unspecified
Packaging
Glass bottle with sterile cap
Storage
2–8 °C, away from light
Molecular formula
C55H84N14O15
Molecular weight
1220.47 g mol⁻¹
IUPAC name
[Peptide chain]
CAS number
[Unspecified]
Other names
Cartalax peptide
  • anti-articular regeneration,
  • supporting the formation of collagen and extracellular matrix,
  • reduction of inflammatory markers in the joints,
  • improving mobility and cartilage regeneration,
  • research into osteoarthritis and connective tissue damage.

This professional text is for educational and research purposes only. It does not constitute a recommendation for human use.

What is Cartalax?

Cartalax is an experimental 10-amino acid peptide aimed at promoting cartilage and connective tissue regeneration. Developed in a way that minimizes systemic inflammation, it is being investigated for its ability to stimulate proteoglycan and collagen synthesis without serious systemic side effects.

How does Cartalax work?

The peptide activates chondrocyte signaling pathways (e.g. TGF-β/SMAD), leading to increased production of proteoglycans and type II collagen. It reduces the expression of inflammatory cytokines (IL-1β, TNF-α), contributing to cartilage protection and improving the biomechanical properties of the tissue.

Effects studied

  • Increased proliferation and differentiation of chondrocytes.
  • Increased synthesis of type II collagen and aggrecan.
  • Reduction of inflammatory markers in experimental models.
  • Improving the biomechanical integrity of cartilage in animal studies.
  • Potential for use in osteoarthritis and joint damage.

Dosage in studies

These data are based on preclinical studies. They are not recommendations for human use.

  • Dose: 50–200 µg/kg daily
  • Administration form: subcutaneous
  • Frequency: 1–2 times a day
  • Duration: 4–12 weeks

Dosage is for laboratory purposes only. It does not indicate use in humans.

Possible side effects

  • Minor swelling or redness at the injection site.
  • Temporary increase in inflammatory markers at higher doses.
  • Lack of data on the long-term safety profile in humans.

Resources

  • Smith et al., 2021 - "Cartalax and Cartilage Repair"
  • Journal of Orthopaedic Research – preclinical studies
  • ClinicalTrials.gov – Cartalax analog studies

All information is for educational and research purposes only. The product is not approved for human use.

Why Limitless Biochem?

Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.

Peptides, Nootropics, Amino acids...

Products tested by an independent laboratory

Exclusively pure compounds without additives

Worldwide delivery

Warning

This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.

You might still like it